Pharma-Bio Serv (PBSV) Enterprise Value (2016 - 2026)
Pharma-Bio Serv's Enterprise Value history spans 16 years, with the latest figure at -$10.6 million for Q1 2026.
- For Q1 2026, Enterprise Value rose 15.07% year-over-year to -$10.6 million; the TTM value through Jan 2026 reached -$10.6 million, up 15.07%, while the annual FY2025 figure was -$10.9 million, 14.84% up from the prior year.
- Enterprise Value reached -$10.6 million in Q1 2026 per PBSV's latest filing, up from -$10.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$10.4 million in Q2 2025 to a low of -$15.9 million in Q1 2024.
- Average Enterprise Value over 5 years is -$13.3 million, with a median of -$13.5 million recorded in 2024.
- Peak YoY movement for Enterprise Value: fell 3.56% in 2023, then increased 22.75% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$14.5 million in 2022, then dropped by 3.56% to -$15.0 million in 2023, then increased by 14.9% to -$12.7 million in 2024, then rose by 14.84% to -$10.9 million in 2025, then grew by 2.71% to -$10.6 million in 2026.
- Per Business Quant, the three most recent readings for PBSV's Enterprise Value are -$10.6 million (Q1 2026), -$10.9 million (Q4 2025), and -$10.7 million (Q3 2025).